An RCT of Mycophenolate Mofetil (MMF) in Fibrotic Hypersensitivity Pneumonitis
Status:
Not yet recruiting
Trial end date:
2025-10-23
Target enrollment:
Participant gender:
Summary
To our knowledge, there is no randomized controlled trial assessing the efficacy of
mycophenolate mofetil (MMF) in the treatment of HP. We aim to perform a randomized study to
assess the efficacy and safety of a regimen consisting of MMF and prednisolone against a
regimen consisting of prednisolone alone for treating fibrotic HP. We hypothesize that the
treatment of patients with fibrotic HP with MMF and prednisolone will be more effective and
safer than treatment with prednisolone alone.
Phase:
Phase 4
Details
Lead Sponsor:
Postgraduate Institute of Medical Education and Research